Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A growing number of genomic studies have generated important discoveries regarding human health and behaviour, but new research from the University of Oxford suggests that scientific advancement is limited by a lack of diversity.

None

The findings show that the people studied in genetic discovery research continue to be overwhelmingly of European descent, but also for the first time reveal that subjects are concentrated in a handful of countries - the UK, US and Iceland, and have specific demographic characteristics. The authors caution that this lack of diversity has potentially huge implications for the understanding and applications of genetic discoveries.

Read more (University of Oxford website)

Similar stories

RECOVERY trial team awarded MRC Impact Prize for Outstanding Team Impact

The Medical Research Council Prize Committee has awarded the RECOVERY trial team the MRC Impact Prize 2022 for Outstanding Team Impact.

Multiple Debilitating Pains – New global study shows the experience of Endometriosis is rooted in a person’s genetics

Researchers at the University of Oxford in collaboration with 25 teams across the world have published the largest study to date of the genetic basis of endometriosis.

Study shows delaying treatment for localised prostate cancer does not increase mortality risk

Active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery, reports the largest study of its kind.

Showcasing Oxford’s translational research for Rare Disease Day

Rare Disease Day is an annual awareness day that aims to educate and raise awareness for the 400 million people worldwide who live with a rare disease.

Prostate cancer AI diagnosis tool begins evaluation in Oxford

New artificial intelligence software that can help to spot prostate cancer is being trialled by researchers at Oxford University Hospitals (OUH) NHS Foundation Trust.

Unlocking the secrets of cAMP signalling in the heart: a pathway to targeted therapeutics

A new Department of Physiology, Anatomy and Genetics study has revealed key new insights into the role of cAMP signalling in both healthy and disease settings within the heart. Researchers have identified new cAMP nanodomains in cardiac muscle cells that have far reaching implications for the treatment of heart disease.